Osprey Medical
  • Technology
    • DyeVert™ PLUS EZ
    • DyeVert™ PLUS
  • Be Kind to Kidneys™
  • Patients
    • About Your Kidneys
    • Patients at Risk
    • Kidney Kindness in the Cath Lab
    • Martha’s Story
    • DyeVert™ Plus System
  • About Us
    • Management
    • Board of Directors
    • News
    • Patents
  • Investors
    • Financial Information
    • Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Contact Us
  • Search
  • Menu

Investors

  • Financial Information
  • Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Contact Us

Osprey Medical is
dedicated to making
angiography safer
for chronic kidney
disease patients.

Osprey Medical designs, develops, and manufactures proprietary devices and monitoring systems that reduce the amount of X-ray dye (contrast) used during commonly performed heart imaging procedures.

Our Mission

To improve outcomes in patients suffering from Chronic Kidney Disease (CKD) by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs.

35%

Revenue growth*

36%

Unit growth*

*Q4 ’18 vs. Q4 ’19

In the News

US Government to Transform Kidney Care

July 12, 2019
Osprey Medical (ASX: OSP) today announces its response to the US President signing an Executive Order aimed at transforming kidney care for more than 37 million Americans with some form of kidney disease. The initiative seeks to prevent kidney failure through better diagnosis, treatment and preventative care.
Read more
https://ospreymed.com/wp-content/uploads/2019/08/white-house.png 610 610 Cat Gilfillen /wp-content/uploads/2017/04/osprey-logo-224w.png Cat Gilfillen2019-07-12 20:50:082019-08-09 01:33:11US Government to Transform Kidney Care
Premier Inc.

AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference

June 21, 2019
Osprey Medical (ASX: OSP) today announces that Dr Anand Prasad, M.D., Director of the Cardiac Catheterization Laboratory at University Health System and Associate Professor of Medicine at UT Health Science Centre at San Antonio, Texas presented the Acute Kidney Injury (AKI) Burden of Illness Study1 at the Premier Breakthroughs 2019 Conference and Exhibition in Nashville, Tennessee on behalf of the study investigators.
Read more
https://ospreymed.com/wp-content/uploads/2018/12/premier-logo.jpg 610 610 Cat Gilfillen /wp-content/uploads/2017/04/osprey-logo-224w.png Cat Gilfillen2019-06-21 20:46:462019-08-09 01:35:22AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference

All Osprey Medical News

Osprey Medical’s product specific labeling indications may vary by geography.

© 2020 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, and Be Kind to Kidneys are registered Trademarks of Osprey Medical, Inc. in the United States and other countries.
  • Contact
  • Resources
  • Privacy
  • Terms of Use

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.

Scroll to top